Vitamin C and Inflammation in the news again
by Dr. Alan Kadish
When we look back at the multiple years of research on the effectiveness of vitamin C and the lack of side effects, let alone the low cost , why are more people not taking this seriously ? In this study the patients only took 500mg twice per day and saw results. The highlighted key points are in the study abstract below.
We know that inflammation is a key process in aging and multiple diseases. The recent study is another clearly scientific rationale for increasing the use of vitamin c daily. If you’re experiencing diabetes or cancer or just concerned about your overall health here is the perfect way to address some of the metabolic problems.
For many more simple, cost effective and disease effective approaches, call us at the Center 541.773.3191.
Effect of vitamin C on inflammation and metabolic markers in hypertensive and/or diabetic obese adults: a randomized controlled trial
Drug Design, Development and Therapy, 07/15/2015
Ellulu MS, et al.
The aim of the study reported was to identify the effect of vitamin C on reducing the levels of inflammatory markers in hypertensive and/or diabetic obese adults. Vitamin C (500 mg twice daily) has potential effects in alleviating inflammatory status by reducing hs–CRP, IL–6, and FBG in hypertensive and/or diabetic obese patients.
- Sixty-four obese patients, who were hypertensive and/or diabetic and had high levels of inflammatory markers, from primary health care centers in Gaza City, Palestine, were enrolled into one of two groups in an open-label, parallel, randomized controlled trial.
- A total of 33 patients were randomized into a control group and 31 patients were randomized into an experimental group.
- The experimental group was treated with 500 mg vitamin C twice a day.
- In the experimental group, vitamin C significantly reduced the levels of high-sensitivity C-reactive protein (hs-CRP), interleukin 6 (IL-6), fasting blood glucose (FBG), and triglyceride (TG) after 8 weeks of treatment (overall: P<0.001); no changes appeared in total cholesterol (TC).
- In the control group, there were significant reductions in FBG and TG (P=0.001 and P=0.026, respectively), and no changes in hs-CRP, IL-6, or TC.
- On comparing the changes in the experimental group with those in the control group at the endpoint, vitamin C was found to have achieved clinical significance in treating effectiveness for reducing hs-CRP, IL-6, and FBG levels (P=0.01, P=0.001, and P<0.001, respectively), but no significant changes in TC or TG were found.
Latest posts by Dr. Alan Kadish, NMD (see all)
- Ever wonder why insurance stock and profits are soaring , at patients expense ? - August 27, 2019
- Heavy metals in your baby food ? - November 11, 2017
- Is it Alzheimer’s, Depression or both , scan the brain - February 24, 2017